Nystatin
Y. Vivian Tsai, Pharm.D., Kathryn Dzintars, Pharm.D., BCPS
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Oropharyngeal candidiasis
- Vulvovaginal candidiasis — clinical/global use; nystatin vaginal formulations are not currently commercially marketed in the U.S. and may require compounding.
- An alternative intravaginal treatment when azoles are unsuitable, including cases of C. glabrata infection.[1][5]
- Cutaneous candidiasis
- Nonesophageal gastrointestinal mucosal candidiasis
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2026 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.